CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 1 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,888,958 | +88.1% | 49,166 | +13.3% | 0.02% | +77.8% |
| Q1 2023 | $1,004,247 | -11.6% | 43,380 | +0.1% | 0.01% | -10.0% |
| Q4 2022 | $1,135,534 | +68.5% | 43,341 | +26.3% | 0.01% | +66.7% |
| Q3 2022 | $674,000 | +5.5% | 34,308 | -6.0% | 0.01% | 0.0% |
| Q2 2022 | $639,000 | -28.1% | 36,508 | -32.8% | 0.01% | -40.0% |
| Q1 2022 | $889,000 | -11.0% | 54,364 | -11.2% | 0.01% | -9.1% |
| Q4 2021 | $999,000 | +42.5% | 61,221 | +11.5% | 0.01% | +57.1% |
| Q3 2021 | $701,000 | -15.5% | 54,903 | -6.6% | 0.01% | 0.0% |
| Q2 2021 | $830,000 | -30.0% | 58,761 | -23.0% | 0.01% | -41.7% |
| Q1 2021 | $1,185,000 | +158.2% | 76,264 | +163.5% | 0.01% | +140.0% |
| Q4 2020 | $459,000 | – | 28,941 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
| Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
| Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
| Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
| Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
| Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
| Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |